SCALEREADY CORPORATE SESSION Scaling Standardized Cell Therapies from Process Development to Clinical Manufacturing
Thursday, June 1, 2023 08:00 AM - 09:00 AM
Room 242AB
Corporate Session
Scaling Standardized Cell Therapies from Process Development to Clinical Manufacturing
Chair
Josh Ludwig, BSc, Global Commercial Director, ScaleReady, USA
Speakers
Michal Besser, PhD., CTO, Davidoff Center, Rabin Medical Center
Stuart Curbishley, Ph.D., Chief Manufacturing and Development Officer, Adthera Bio
Alex Spyridonidis, PhD, Director Institute of Cell Therapy, University of Patras, Greece
Objectives
Chair
Josh Ludwig, BSc, Global Commercial Director, ScaleReady, USA
Speakers
Michal Besser, PhD., CTO, Davidoff Center, Rabin Medical Center
Stuart Curbishley, Ph.D., Chief Manufacturing and Development Officer, Adthera Bio
Alex Spyridonidis, PhD, Director Institute of Cell Therapy, University of Patras, Greece
Objectives
- Streamlining cell therapy processes and impact on functionality
- Key objectives in standardizing cell therapy processes and outcomes from research to clinic
- Correctly introducing automation without perpetuating complexities and risk
- Overcoming scaling breakdowns between research, PD and commercial departments
- Important milestones to achieve standardized, scalable cell therapy production for accelerated patient accessibility
Sponsored by:
Alexandros Spyridonidis MD, PhD
Professor of Hematology and Director
BMT Unit and Institute of Cell Therapy
Speaker
Professor of Hematology and Director
BMT Unit and Institute of Cell Therapy
Speaker